Breaking News Instant updates and real-time market news.

ATRA

Atara Biotherapeutics

$16.15

0.1 (0.62%)

08:05
10/18/16
10/18
08:05
10/18/16
08:05

Atara Biotherapeutics granted access to PRIME regulatory support for EBV-PTLD

Atara Biotherapeutics announced that the European Medicines Agency Committee for Medicinal Products for Human Use, or CHMP, and Committee for Advanced Therapies, or CAT, have granted access to the EMA's newly established Priority Medicines, or PRIME, regulatory initiative for EBV-CTL in the treatment of patients with rituximab refractory EBV-PTLD following hematopoietic cell transplant, or HCT. PRIME provides early and enhanced regulatory support to optimize regulatory applications and accelerate the review of medicines that address a high unmet need. EBV-CTL is an investigational therapy in which a healthy donor's T-cells are stimulated to recognize EBV antigens, or viral proteins, expressed in the cells of certain liquid and solid tumors, as well as in autoimmune diseases.

ATRA Atara Biotherapeutics
$16.15

0.1 (0.62%)

03/29/16
SBSH
03/29/16
NO CHANGE
SBSH
Citi lays out potential targets for next biotech M&A wave
Citi analyst Yigal Nochomovitz believes the setup for the next acquisition cycle in the biotech space is here, but that biotech management's desire to do deals is the missing catalyst. He thinks another one-to-three quarters is needed before "reset valuations are better absorbed as the new reality." Large cap pharma and biotech companies are cash rich and have signaled repeatedly over last year that they are looking for new assets, Nochomovitz tells investors in a research note. He sees a "greater probability" of a takeover over the next 12-18 months for Ardelyx (ARDX), Medivation (MDVN), Ophthotech (OPHT), Puma Biotechnology (PBYI), Portola Pharmaceuticals (PTLA), Ultragenyx (RARE), Relypsa (RLYP) and Versartis (VSAR). He sees a "moderate probability" of a takeover for Anthera (ANTH), Loxo Oncology (LOXO), MacroGenics (MGNX) and Mirati Therapeutics (MRTX). Nochomovitz also sees a "lower probability" of a buyout for Atara Biotherapeutics (ATRA), Chimerix (CMRX), Keryx (KERX) and Mirna Therapeutics (MIRN).
07/08/16
07/08/16
NO CHANGE

Atara unlikely to encounter same side effects as Juno, says JMP Securities
After the FDA placed Juno's (JUNO) lead clinical program, JCAR015, on hold, JMP Securities says that the side effects seen among Juno's patients probably won't be seen among Atara's patients. The firm keeps a $34 price target and Outperform rating on Atara.
09/15/16
GSCO
09/15/16
DOWNGRADE
Target $16
GSCO
Sell
Atara Biotherapeutics downgraded to Sell from Neutral at Goldman
Goldman Sachs analyst Salveen Richter downgraded Atara Biotherapeutics to Sell saying there are no major pipeline catalysts until late 2017. Further, the analyst views Atara's transition to in-house manufacturing by the end of 2016 as a risk pending FDA clearance. She cut her price target for the shares to $16 from $23.
09/15/16
09/15/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AMC Networks (AMCX) downgraded to Hold from Buy at Stifel with analyst Benjamin Mogil citing weak industrywide ad trends for scripted shows after their first year. 2. Atara Biotherapeutics (ATRA) downgraded to Sell from Neutral at Goldman with analyst Salveen Richter saying there are no major pipeline catalysts until late 2017. 3. Helmerich & Payne (HP) downgraded to Hold from Buy at Argus with analyst Bill Selesky saying that the company is increasingly relying on lower priced spot contracts rather than higher priced term contracts. 4. Cognizant (CTSH) downgraded to Neutral from Buy at Goldman with analyst James Schneider saying cyclical headwinds in the company's Financials and Healthcare units will persist through the first ha lf of 2017. 5. Penske Automotive (PAG) downgraded to Hold from Buy at Gabelli citing the recent strength in shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

HAL

Halliburton

$56.40

3.39 (6.40%)

09:05
01/23/18
01/23
09:05
01/23/18
09:05
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$91.89

0.82 (0.90%)

09:04
01/23/18
01/23
09:04
01/23/18
09:04
Hot Stocks
Procter & Gamble sees stronger earnings growth in Q4 than Q3 »

Views tax act as a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

WPP

WPP

$95.32

-0.21 (-0.22%)

09:04
01/23/18
01/23
09:04
01/23/18
09:04
Downgrade
WPP rating change  »

WPP downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$63.94

0.23 (0.36%)

, CHTR

Charter

$370.25

4.2 (1.15%)

09:03
01/23/18
01/23
09:03
01/23/18
09:03
Hot Stocks
T-Mobile closes Layer3 TV acquisition, prepares to take on cable, satellite TV »

T-Mobile US (TMUS)…

TMUS

T-Mobile

$63.94

0.23 (0.36%)

CHTR

Charter

$370.25

4.2 (1.15%)

CMCSA

Comcast

$42.89

0.39 (0.92%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 02

    Feb

TSLA

Tesla

$351.56

1.54 (0.44%)

09:03
01/23/18
01/23
09:03
01/23/18
09:03
Periodicals
Tesla CEO sees path to trillion-dollar company within 10 years »

"I actually see the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABC

AmerisourceBergen

$102.66

2.6 (2.60%)

09:02
01/23/18
01/23
09:02
01/23/18
09:02
Recommendations
AmerisourceBergen analyst commentary  »

AmerisourceBergen price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

XPER

Xperi

$22.50

-0.25 (-1.10%)

09:01
01/23/18
01/23
09:01
01/23/18
09:01
Hot Stocks
Xperi partners with ARCloud to bring music recognition to hybrid ratio »

Xperi Corporation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
01/23/18
01/23
09:00
01/23/18
09:00
General news
U.S. equities are relatively subdued »

U.S. equities are…

FQVLF

First Quantum Minerals

$15.30

-0.01 (-0.07%)

08:59
01/23/18
01/23
08:59
01/23/18
08:59
Downgrade
First Quantum Minerals rating change  »

First Quantum Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$53.46

1.55 (2.99%)

08:59
01/23/18
01/23
08:59
01/23/18
08:59
Hot Stocks
Verizon says not considering large media acquisition »

Says remaining a partner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

SANM

Sanmina

$27.08

-8.35 (-23.57%)

08:59
01/23/18
01/23
08:59
01/23/18
08:59
Recommendations
Sanmina analyst commentary  »

Sanmina price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

JMBA

Jamba

08:59
01/23/18
01/23
08:59
01/23/18
08:59
Technical Analysis
Technical Take: Jamba down sharply on 2.1M share Block Trade »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

TWTR

Twitter

$23.34

-0.31 (-1.31%)

08:57
01/23/18
01/23
08:57
01/23/18
08:57
Hot Stocks
Twitter COO Anthony Noto resigns to accept CEO role at other company »

Twitter announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

08:57
01/23/18
01/23
08:57
01/23/18
08:57
General news
Redbook Store Sales data reported »

Week of 1/20 Redbook…

SANM

Sanmina

$27.10

-8.35 (-23.55%)

08:56
01/23/18
01/23
08:56
01/23/18
08:56
Recommendations
Sanmina analyst commentary  »

Sanmina price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

WWD

Woodward

$81.02

0.52 (0.65%)

08:56
01/23/18
01/23
08:56
01/23/18
08:56
Initiation
Woodward initiated  »

Woodward re-initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

TWTR

Twitter

$23.32

-0.34 (-1.44%)

08:55
01/23/18
01/23
08:55
01/23/18
08:55
Hot Stocks
Breaking Hot Stocks news story on Twitter »

Twitter announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

GE

General Electric

$16.17

-0.09 (-0.55%)

, NFLX

Netflix

$227.58

7.12 (3.23%)

08:55
01/23/18
01/23
08:55
01/23/18
08:55
Options
Notable open interest changes for January 23rd »

Monday's total…

GE

General Electric

$16.17

-0.09 (-0.55%)

NFLX

Netflix

$227.58

7.12 (3.23%)

AAPL

Apple

$177.00

-1.46 (-0.82%)

BAC

Bank of America

$31.94

0.22 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 30

    Jan

  • 01

    Feb

  • 15

    Feb

JMBA

Jamba

$9.14

-0.01 (-0.11%)

08:54
01/23/18
01/23
08:54
01/23/18
08:54
Syndicate
Jamba 2.1M share Block Trade priced at $8.25 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ANET

Arista Networks

$275.68

4.84 (1.79%)

08:54
01/23/18
01/23
08:54
01/23/18
08:54
Recommendations
Arista Networks analyst commentary  »

Arista Networks price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 21

    Feb

  • 26

    Feb

  • 13

    Mar

  • 14

    Mar

FSLR

First Solar

$68.96

-1.07 (-1.53%)

, TSLA

Tesla

$351.56

1.54 (0.44%)

08:53
01/23/18
01/23
08:53
01/23/18
08:53
Recommendations
First Solar, Tesla, JinkoSolar, JA Solar, Sunrun, Vivint Solar analyst commentary  »

30% solar import tariff…

FSLR

First Solar

$68.96

-1.07 (-1.53%)

TSLA

Tesla

$351.56

1.54 (0.44%)

JKS

JinkoSolar

$23.37

-0.8 (-3.31%)

JASO

JA Solar

$7.46

-0.01 (-0.13%)

RUN

Sunrun

$6.04

0.1 (1.68%)

VSLR

Vivint Solar

$3.55

-0.15 (-4.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$53.46

1.55 (2.99%)

08:52
01/23/18
01/23
08:52
01/23/18
08:52
Hot Stocks
Breaking Hot Stocks news story on Verizon »

Verizon says integration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

JWN

Nordstrom

$52.82

0.82 (1.58%)

08:52
01/23/18
01/23
08:52
01/23/18
08:52
Downgrade
Nordstrom rating change  »

William Blair downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LITE

Lumentum

$45.20

-3.65 (-7.47%)

08:51
01/23/18
01/23
08:51
01/23/18
08:51
Recommendations
Lumentum analyst commentary  »

Lumentum price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

NDAQ

Nasdaq

$80.63

0.56 (0.70%)

, CBOE

Cboe Global Markets

$134.56

0.68 (0.51%)

08:49
01/23/18
01/23
08:49
01/23/18
08:49
Periodicals
Nasdaq assessing bitcoin futures that are different to rivals, CNBC reports »

Nasdaq (NDAQ) is…

NDAQ

Nasdaq

$80.63

0.56 (0.70%)

CBOE

Cboe Global Markets

$134.56

0.68 (0.51%)

CME

CME Group

$155.45

1.17 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 01

    Feb

  • 09

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.